CDNA vs PATH
CareDx Inc (CDNA) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
CareDx Inc (CDNA) is a diagnostics & research company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported CDNA revenue for 2024-12-31 was $333.8M. Net income was $52.5M. Revenue was up 19.1% from 2023-12-31 to 2024-12-31. CDNA currently screens at market cap $1.18B.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
CDNA currently screens at market cap $1.18B. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the CDNA and PATH stock pages for the full models.
Not investment advice.